文献速递肿瘤 PET/CT

在肿瘤患者中区分高[68Ga]Ga-FAPI-04摄取的良性病变与恶性病变:动态全身[68Ga]Ga-FAPI-04 PET/CT的启示

Distinguishing benign from malignant lesions with high [68 Ga]Ga-FAPI-04 uptake in oncology patients: Insights from dynamic total-body [68 Ga]Ga-FAPI-04 PET/CT.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2024-12-12

本研究对17例肿瘤患者行注射后0-60分钟动态全身[68Ga]Ga-FAPI-04 PET/CT,分析58个恶性病变和55个炎症病变的动力学参数。恶性病变K1和vB高于良性病变,而k3低于良性病变;基于K1、k3和vB将病变分为低、中、高恶性概率组,恶性概率分别为0%、50.7%和92.0%(P<0.001)。

要点

  • 恶性病变K1为0.277±0.217 ml/ccm/min,高于良性病变的0.221±0.216 ml/ccm/min(P=0.011)。
  • 恶性病变vB为0.042±0.007,高于良性病变的0.013±0.004(P<0.001)。
  • 恶性病变k3为0.267±0.041 1/min,低于良性病变的0.481±0.085 1/min(P=0.008)。

核心结论

  • 动力学参数尤其K1、k3和vB值有潜力作为影像生物标志物,用于区分肿瘤患者中高[68Ga]Ga-FAPI-04摄取的良性病变与恶性病变。
  • 这些参数反映病变的代谢异质性,可能提高肿瘤影像诊断准确性。

研究设计与样本

  • 对17例肿瘤患者行注射后0-60分钟动态全身[68Ga]Ga-FAPI-04 PET/CT扫描。
  • 对高[68Ga]Ga-FAPI-04摄取的良性和恶性病变生成时间-放射性曲线(TAC)。
  • 采用可逆两组织室模型(2T4k)推导动力学参数,包括K1、k2、k3、k4、vB和VT。
  • 采用受试者工作特征(ROC)曲线分析确定区分良恶性病变的截断值。

主要发现

  • 研究纳入58个恶性病变和55个炎症病变,均具有高[68Ga]Ga-FAPI-04摄取。
  • 恶性病变K1为0.277±0.217 ml/ccm/min,高于良性病变的0.221±0.216 ml/ccm/min(P=0.011)。
  • 恶性病变vB为0.042±0.007,高于良性病变的0.013±0.004(P<0.001)。
  • 恶性病变k3为0.267±0.041 1/min,低于良性病变的0.481±0.085 1/min(P=0.008)。
  • 基于K1、k3和vB值将病变分为低、中、高恶性概率组,恶性概率分别为0%、50.7%和92.0%(P<0.001)。

关键数值与推荐

  • 恶性病变K1为0.277±0.217 ml/ccm/min,良性病变为0.221±0.216 ml/ccm/min(P=0.011)。
  • 恶性病变vB为0.042±0.007,良性病变为0.013±0.004(P<0.001)。
  • 恶性病变k3为0.267±0.041 1/min,良性病变为0.481±0.085 1/min(P=0.008)。
  • 低、中、高恶性概率组的恶性概率分别为0%、50.7%和92.0%(P<0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: While [68 Ga]Ga-FAPI-04 PET/CT is widely used in various malignant tumors diagnosis, its specificity is challenged by high uptake in benign lesions such as inflammatory lymphadenopathy, bone fractures, and degenerative changes. This study aimed to quantitatively assess and characterize the metabolic heterogeneity of [68 Ga]Ga-FAPI-04 uptake in benign and malignant lesions using dynamic total-body PET/CT. METHODS: Dynamic total-body [68 Ga]Ga-FAPI-04 PET/CT scans (0-60 min post-injection) were performed on 17 oncology patients. Time-activity curves (TACs) were generated for benign and malignant lesions with high [68 Ga]Ga-FAPI-04 uptake. The reversible two-tissue compartment model (2T4k) was used to derive kinetic metrics, including K1, k2, k3, k4, vB and VT. Receiver operating characteristic (ROC) curve analysis was used to determine the cut-off values for differentiating benign and malignant lesions. RESULTS: The study included 58 malignant and 55 inflammatory lesions with high [68 Ga]Ga-FAPI-04 uptake. Malignant lesions exhibited higher K1 (0.277 ± 0.217 ml/ccm/min vs. 0.221 ± 0.216 ml/ccm/min, P = 0.011), vB (0.042 ± 0.007 vs. 0.013 ± 0.004, P < 0.001), and lower k3 (0.267 ± 0.041 1/min vs. 0.481 ± 0.085 1/min, P = 0.008) compared to benign lesions. Lesions were classified into low, medium, and high-probability groups for being malignant based on K1, k3 and vB values, with probabilities of 0%, 50.7%, and 92.0%, respectively (P < 0.001). CONCLUSIONS: Kinetic metrics, particularly K1, k3 and vB values, show promise as imaging biomarkers for distinguishing between benign and malignant lesions with high [68 Ga]Ga-FAPI-04 uptake in oncology patients. These metrics reflect the metabolic heterogeneity of the lesions and may improve diagnostic accuracy in oncological imaging.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Chen R, Yang X, Li L, et al. Distinguishing benign from malignant lesions with high [68 Ga]Ga-FAPI-04 uptake in oncology patients: Insights from dynamic total-body [68 Ga]Ga-FAPI-04 PET/CT. Eur J Nucl Med Mol Imaging. 2024. PMID: 39665998. doi:10.1007/s00259-024-07029-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。